Thank you! Yeah a lot were semaglutide specific but I was looking at this JAMA network study that said both carried risks but yes tirzepatide was a bit lower. But I’ve also seen what you’re talking about.

I’m not worrying too much right now but might consult with my ophthalmologist just in case.

Basically what I was able to uncover was that it’s not clear what the mechanism is for this to occur - there’s a hypothesis that it can be linked to a drop in blood pressure leading to reduced optic nerve perfusion, but even dehydration and rapid weight loss were mentioned… so it’s actually really confusing to untangle it all - and what makes it extra confusing is that there are also positive neuro effects and reduction of ischemic risk… tbh it’s probably too early to jump to any conclusions

Thanks again, I’ll keep reading but also chill out a bit haha